v3.25.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS

The consolidated financial statements include all accounts of the entities as of the reporting period ending dates and for the reporting periods as follows:

 

Name of
consolidated

subsidiary

 

State or other

jurisdiction of
incorporation or
organization

 

Date of

incorporation

or formation

  Attributable
interest as of
December 31, 2025		   Attributable
interest as of
December 31, 2024		 
               
Global BioMedical, Inc.  Nevada  April 18, 2017   90.9%   90.9%
Global BioLife, Inc.  Nevada  April 14, 2017   81.8%   81.8%
BioLife Sugar, Inc  Nevada  April 23, 2018   90.9%   90.9%
Happy Sugar Inc  Nevada  August 17, 2018   81.8%   81.8%
Sweet Sense Inc.  Nevada  April 30, 2018   95.5%   95.5%
Global Sugar Solutions Inc.  Nevada  November 7, 2019   100%   100%
Impact Biolife Science, Inc.  Nevada  April 13, 2021   100%   100%
DSS Biomedical International, Inc.  Nevada  April 9, 2021   100%   100%
DSS Biolife International, Inc.  Nevada  April 9, 2021   100%   100%